A new case series urges clinicians to keep cold agglutinin disease (CAD) on their radar when treating elderly patients…
Articles by Steve Bryson, PhD
A proof-of-concept study designed to test a new tablet formulation of the experimental therapy ANX1502 in people with cold…
Riliprubart (SAR445088), a potential successor to Enjaymo (sutimlimab-jome) as a cold agglutinin disease (CAD) treatment, may achieve therapeutic…
Nearly half of people without symptoms of cold agglutinin disease (CAD) who undergo a lung transplant test positive for cold…
The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) scale, a widely used questionnaire to assess fatigue, is reliable, valid, and…
Annexon Biosciences’ new tablet formulation of its experimental therapy ANX1502 reduced key clinical and biomarker measures in the three…
Nearly half of children and teens with autoimmune hemolytic anemia (AIHA) — a group of disorders that includes cold…
Clinicians detected B-cell lymphoma, a type of blood cancer, in a 53-year-old man two years after he was diagnosed with…
A boy in China was diagnosed with a rare case of cold agglutinin disease (CAD) associated with a…
Researchers said a case of cold agglutinin disease (CAD) in a 92-year-old man in Pakistan illustrates the challenges of…